Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of rivastigmine tartrate

A technology of rivastigmine bitartrate and tartaric acid, which is applied in the field of preparation of high-purity rivastigmine bitartrate, can solve the problems of high synthesis cost and high market price of rivastigmine bitartrate, and is beneficial to large-scale industrial production and eliminates the three wastes. Effects of reduced processing burden, easy separation, recovery, and recycling

Inactive Publication Date: 2013-01-30
哈药集团人民同泰医药股份有限公司
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the high synthetic cost of rivastigmine hydrotartrate leads to high market price, so it is necessary to continuously study the improvement of its synthetic route to reduce the cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of rivastigmine tartrate
  • Preparation method of rivastigmine tartrate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] (1) Add (S)-3-(1-(dimethylamino)ethyl)phenol (19.8g, 0.12mol) and 250ml pyridine into a three-necked flask, and add methylethylcarbamoyl chloride (15.9g, 0.13mol) , reflux under reduced pressure for 3 hours, vacuum degree control 0.06MPa-0.08MPa, temperature 60°C-75°C, after recovering pyridine, add 100ml isopropyl ether for extraction, wash with 0.1mol / L NaOH solution, wash with water, dry over anhydrous magnesium sulfate, reduce The iso-ether was removed by pressure evaporation, and after vacuum drying, 29.2 g of rivastigmine free base was obtained as a yellow liquid, with a yield of 97.5%.

[0017] (2) Dissolve the product obtained in 1 in 180ml of 1.2-propanediol, add L-(+)-tartaric acid (18g, 0.12mol), heat and stir at 90°C, after the reaction liquid is clear, cool down to room temperature naturally under stirring, and precipitate The product was suction filtered and dried to obtain 42.5 g of rivastigmine bitartrate finished product, with a yield of 91%.

Embodiment 2

[0019] (1) Add (S)-3-(1-(dimethylamino)ethyl)phenol (19.8g, 0.12mol) and acetone 130ml into a three-necked flask, add 4.5g of anhydrous sodium carbonate to activate for a certain period of time, add Methylethylcarbamoyl chloride (15.9g, 0.13mol), react for 8 hours, after recovery of acetone, add 110ml of dichloromethane and 150ml of water, adjust the pH to 3 with hydrochloric acid, extract, discard the organic phase, add 150ml of dichloromethane to the water layer , add concentrated ammonia water to adjust the pH to 10, separate the aqueous layer, wash the organic phase with 100ml of water, separate the dichloromethane layer and evaporate the solvent under reduced pressure to obtain 29.3 g of rivastigmine free base as a yellow liquid with a yield of 97.6%.

[0020] (2) Dissolve the product obtained in 1 in 200ml of isopropanol, add L-(+)-tartaric acid (18g, 0.12mol), and heat to reflux. After the reaction solution is clear, it is cooled to room temperature naturally after stirr...

Embodiment 3

[0022] (1) Add (S)-3-(1-(dimethylamino)ethyl)potassium phenate (19.8g, 0.12mol) and 130ml of tetrahydrofuran into a three-necked flask, add methylethylcarbamoyl bromide (15.9g, 0.13 mol), reacted at 50°C for 1 hour, recovered the solvent, added 110ml of ethyl acetate and 150ml of water, adjusted the pH to 3 with hydrochloric acid, extracted, discarded the organic phase, added 150ml of ethyl acetate to the aqueous layer, and added concentrated ammonia water to adjust the pH to 10. Separate the water layer, wash the organic phase with 100 ml of water, separate the ethyl acetate layer and evaporate the solvent under reduced pressure to obtain 28.9 g of rivastigmine free base as a yellow liquid, with a yield of 96.3%.

[0023] (2) Dissolve the product obtained in 1 in 200ml of isopropanol, add L-(+)-tartaric acid (18g, 0.12mol), and heat to reflux. After the reaction solution is clear, it is cooled to room temperature naturally after stirring, and the weight is obtained after separ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of rivastigmine tartrate, which comprises the following steps of: carrying out condensation on compound II and compound III in proper solvent with catalyst or without catalyst to obtain component I; and salifying the compound I and L-(+)-tartaric acid in proper solvent to obtain the rivastigmine tartrate, wherein R1 is H, K or Na, and R is Cl, Br, I, CN or SCN. The method has the advantages of being short in process route, mild in reaction, easy in recovery of reagent, high in yield and the like, thus being suitable for industrial production.

Description

technical field [0001] The invention relates to a method for preparing rivastigmine bitartrate as an anti-senile dementia drug, in particular to a method for preparing high-purity rivastigmine bitartrate. Background technique [0002] Rivastigmine bitartrate is a second-generation selective central, reversible, long-acting non-competitive acetylcholinesterase (AchEI) and butyrylcholinesterase (BchE) inhibitor developed by Novartis, which can not only be used for the treatment of Moderate and mild senile dementia, and has a more significant effect on late-stage severe AD patients. It is currently internationally recognized and the highest-rated drug for improving symptoms of Alzheimer's dementia. However, the high synthetic cost of rivastigmine hydrotartrate leads to high market price, so it is necessary to continuously study the improvement of its synthetic route to reduce the cost. Invention content: [0003] The present invention improves and optimizes an industrialized...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C271/44C07C59/255C07C269/06C07C51/41
Inventor 刘占滨刘春凤秦雅英范宁王敬伟周辉金连玉张晓霞
Owner 哈药集团人民同泰医药股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com